Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

 
 
DownloadE-Mail
  The fast-growing business of Serine ADP-ribosylation

Longarini, E. J., & Matić, I. (2022). The fast-growing business of Serine ADP-ribosylation. DNA Repair (Amst), 118, 103382. doi:10.1016/j.dnarep.2022.103382.

Item is

Basisdaten

einblenden: ausblenden:
Genre: Zeitschriftenartikel

Externe Referenzen

einblenden:
ausblenden:
externe Referenz:
https://www.ncbi.nlm.nih.gov/pubmed/35963141 (beliebiger Volltext)
Beschreibung:
-
OA-Status:
Keine Angabe

Urheber

einblenden:
ausblenden:
 Urheber:
Longarini, E. J.1, Autor           
Matić, I.1, Autor           
Affiliations:
1Matic – ADP-ribosylation in DNA Repair and Ageing, Research Groups, Max Planck Institute for Biology of Ageing, Max Planck Society, ou_1942299              

Inhalt

einblenden:
ausblenden:
Schlagwörter: *ADP-Ribosylation DNA Damage DNA Repair Poly (ADP-Ribose) Polymerase-1/metabolism Protein Processing, Post-Translational *Serine/metabolism ADPribosylation Parp1 Proteomics
 Zusammenfassung: ADP-ribosylation (ADPr) is a widespread post-translational modification (PTM) spanning all kingdoms of life. It is employed by bacteria and viruses in their war against the host, and by eukaryotes to regulate many physiological processes, across almost all cellular compartments. PARP1, the founding member of the PARP family, is an early sensor of single- and double-strand breaks and catalyzes ADPr to mediate DNA damage repair. The recent discovery of Serine-ADPr and the PARP1 accessory factor HPF1 has brought a momentous change to the field. Bolstered by innovative ways to study ADPr, new and exciting research directions are rapidly emerging. In this review we explore our understanding of the HPF1/PARP1-mediated ADPr signaling pathway in DNA damage. We focus on the mechanistic steps leading to Serine-ADPr and its relevance in the DNA damage response. We discuss important technological advances that have enabled a nuanced study of Serine-ADPr, and conclude with an overview of the role of PARP inhibitors in cancer therapy.

Details

einblenden:
ausblenden:
Sprache(n):
 Datum: 2022-07-292022-07-29
 Publikationsstatus: Erschienen
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: -
 Identifikatoren: Anderer: 35963141
DOI: 10.1016/j.dnarep.2022.103382
ISSN: 1568-7856 (Electronic)1568-7856 (Linking)
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: DNA Repair (Amst)
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: -
Seiten: - Band / Heft: 118 Artikelnummer: - Start- / Endseite: 103382 Identifikator: -